Table 3.
NF-κB signaling target genes | Cd83 | Csf1 | IL15 | Irf1 | Icam1 | Il1b | Csf3 | Mmp9 | Ccnd1 |
---|---|---|---|---|---|---|---|---|---|
TF binding site | |||||||||
NF-Kap | x | x | x | x | x | x | x | x | x |
C/EBP | x | x | x | x | x | x | x | x | - |
C/EBPa | x | x | x | - | x | - | x | x | - |
AML-1a | x | x | x | x | x | x | x | x | x |
CdxA | x | x | x | x | x | x | x | x | x |
CRE-BP | x | x | x | x | x | x | - | - | - |
deltaE | x | x | x | x | x | x | x | x | x |
GATA-1 | x | x | x | x | x | x | x | x | x |
GATA-2 | x | x | x | x | x | x | x | x | x |
GATA-3 | x | x | x | x | x | - | x | x | x |
GATA-X | x | x | x | x | x | x | x | - | x |
HSF2 | x | x | x | x | x | x | - | x | - |
MZF1 | x | x | x | x | x | x | x | x | x |
Nkx-2. | x | x | x | x | x | x | x | x | x |
Oct-1 | x | x | x | x | x | x | x | x | - |
SRY | x | x | x | x | x | x | x | x | x |
TATA | x | x | x | x | x | x | - | x | x |
Fold regulation | |||||||||
venom- and LPS- vs. LPS-treated | 29.4 | 117.8 | 13.4 | 14.0 | 17.6 | −4.4 | −31.7 | −5.8 | −7.4 |
venom-treated vs. untreated | 3.0 | 55.9 | 2.5 | 2.0 | 1.2 | 5.9 | 5.5 | 1.6 | −2.7 |